NewAmsterdam (NAMS) via Frazier Lifesciences (FLAC) deck
NewAmsterdam Pharma is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases.
![](/content/images/size/w1304/2022/07/g381095ex99_2p1g1-1.jpg)
NewAmsterdam Pharma is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases.